A New Way in Treating

METABOLIC DISEASES

A Better Way of Living

HEALTHY LIFE

ABOUT NOVMETAPHARMA

NovMetaPharma is a company that specialized in developing first-in-class drugs with differentiated mechanisms related to metabolic disease. We will lead the global market for treating metabolic diseases through ingenious technology and efficient development systems.
Research Areas

NovMetaPharma is conducting various researches for the treatment of metabolic diseases.

Research Team

NovMetaPharma focuses on the R&D of new drugs through core domestic and international research teams.

Key Pipelines

NovMetaPharma is expanding its pipeline of new drugs by continuously conducting R&D.

OUR PARTNERS

NovMetaPharma is continuously seeking R&D cooperation for new drug development by establishing the best research infrastructure network in each area.

LATEST NEWS

Here are new updates from NovMetaPharma.
Notice
Progress of NovDB...

US FDA is conducting Phase 2c cl...

Notice
Submission of man...

NovMetaPharma and NovMetaHealth ...

IR
Company IR Book

Latest Company IR Book